{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:16:03Z","timestamp":1792671363183,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Alongside being contraceptives, progestins have been investigated as potential anti-inflammatory and analgesic therapies for use in painful gynaecological conditions. This review aims to synthesise evidence pertaining to the efficacy of progestins as analgesics for use in endometriosis, fibroids and pre-menstrual syndrome (PMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of the extant literature investigating the analgesic efficacy of progestins compared to any comparator interventions for individuals with the three specified gynaecological conditions. The search was carried out across the PubMed and CENTRAL databases on 7 April 2024 for randomised control trials (RCTs) published in the peer-reviewed literature from 2000 onwards. Data pertaining to analgesic efficacy, assessed by changes in pain indices\/scores before and after treatment, were synthesised narratively. Data pertaining to adverse effect frequency and changes in bone mineral density (BMD) were also synthesised narratively. Risk of bias was assessed using the Cochrane risk of bias 2 tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary search identified 1220 potentially eligible RCTs of which 21 were ultimately included; 19 RCTs related to endometriosis, two related to fibroids and zero related to PMS. Quality assessment identified nine studies to be at a low risk of bias, nine studies with some concerns surrounding bias and three studies to be at a high risk of bias. The included studies represented a total of 2745 participants of whom 1317 were treated with a\u00a0progestin and 1428 received a comparator intervention. In 18 of the 19 studies concerning endometriosis, progestins produced a statistically significant reduction in pain, further, in five instances progestins were more efficacious in reducing pain than comparator interventions. In both studies on fibroids, progestins produced significant reductions in pain, however, statistically significant differences compared to comparator interventions were not demonstrated. The most frequently cited adverse effect of progestins was spotting\/irregular bleeding whilst those receiving comparator interventions most often reported hot flushes; cited in 12 and seven studies respectively. Five studies assessed the impact of progestins and comparators on BMD. Three studies found progestins significantly reduced BMD, however, in these instances reductions were significantly lower than those produced by comparator interventions and in two studies were not statistically significant after 12\u00a0months of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our review demonstrates the potential scope for the use of progestins as analgesics in the management of pain associated with endometriosis. Further research will need to be conducted to identify their efficacy in the management of pain associated with fibroids and PMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-025-07957-0","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:31:16Z","timestamp":1741692676000},"page":"1511-1533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The efficacy of progestins in managing pain associated with endometriosis, fibroids and pre-menstrual syndrome: a systematic review"],"prefix":"10.1007","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1256-7360","authenticated-orcid":false,"given":"Connor Luke","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahantesh","family":"Karoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"7957_CR1","unstructured":"Edwards M, Can AS Progestin [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563211\/ (2023). Accessed 10 December 2024."},{"key":"7957_CR2","first-page":"1","volume-title":"Yen and Jaffe\u2019s Reproductive Endocrinology","author":"CR McCartney","year":"2019","unstructured":"McCartney CR, Marshall JC (2019) Chapter 1 - Neuroendocrinology of Reproduction. In: Strauss JF, Barbieri RL (eds) Yen and Jaffe\u2019s Reproductive Endocrinology, 8th edn. Elsevier, Philadelphia, pp 1\u201324","edition":"8"},{"key":"7957_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.contraception.2022.03.016","volume":"112","author":"L Han","year":"2022","unstructured":"Han L, Creinin MD, Hemon A, Glasier A, Chen MJ, Edelman A (2022) Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception. Contraception 112:43\u20137. https:\/\/doi.org\/10.1016\/j.contraception.2022.03.016","journal-title":"Contraception"},{"issue":"10","key":"7957_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/17512433.2020.1821649","volume":"13","author":"C Bastianelli","year":"2020","unstructured":"Bastianelli C, Farris M, Bruni V, Rosato E, Brosens I, Benagiano G (2020) Effects of progestin-only contraceptives on the endometrium. Expert Rev Clin Pharmacol 13(10):1103\u20131123","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3\u20134","key":"7957_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1098-8823(03)00050-9","volume":"71","author":"K Sales","year":"2003","unstructured":"Sales K, Jabbour H (2003) Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 71(3\u20134):97\u2013117","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"7957_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/aji.12552","volume":"76","author":"G Grandi","year":"2016","unstructured":"Grandi G, Mueller M, Bersinger N, Papadia A, Nirgianakis K, Cagnacci A et al (2016) Progestin suppressed inflammation and cell viability of tumor necrosis factor-\u03b1-stimulated endometriotic stromal cells. Am J Obstet Gynecol 76(4):292\u2013298. https:\/\/doi.org\/10.1111\/aji.12552","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"7957_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/molehr\/2.6.433","volume":"2","author":"B van der Burg","year":"1996","unstructured":"van der Burg B, van der Saag PT (1996) Nuclear factor-kappa-B\/steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol Hum Reprod 2(6):433\u2013438","journal-title":"Mol Hum Reprod"},{"key":"7957_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07878-4","author":"T Kupec","year":"2024","unstructured":"Kupec T, Wagels L, Caspers R, Meyer-Wilmes P, Najjari L, Stickeler E et al (2024) Predictors of anxiety in endometriosis patients. Arch Gynecol Obstet. https:\/\/doi.org\/10.1007\/s00404-024-07878-4","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"7957_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrendo.2013.255","volume":"10","author":"P Vercellini","year":"2014","unstructured":"Vercellini P, Vigan\u00f2 P, Somigliana E, Fedele L (2014) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10(5):261\u2013275","journal-title":"Nat Rev Endocrinol"},{"key":"7957_CR10","unstructured":"World Health Organization. Endometriosis [Internet]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/endometriosis (2023). Accessed 20 March 2024."},{"issue":"379","key":"7957_CR11","doi-asserted-by":"publisher","first-page":"e070750","DOI":"10.1136\/bmj-2022-070750","volume":"2022","author":"AW Horne","year":"2022","unstructured":"Horne AW, Missmer SA (2022) Pathophysiology, diagnosis, and management of endometriosis. BMJ 2022(379):e070750","journal-title":"BMJ"},{"issue":"7","key":"7957_CR12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.fertnstert.2016.10.022","volume":"106","author":"P Vercellini","year":"2016","unstructured":"Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S (2016) Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril 106(7):1552\u20131571. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.10.022","journal-title":"Fertil Steril"},{"issue":"3","key":"7957_CR13","doi-asserted-by":"publisher","first-page":"CD010813","DOI":"10.1002\/14651858.CD010813.pub2","volume":"2014","author":"M de Bastos","year":"2014","unstructured":"de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T et al (2014) Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev 2014(3):CD010813. https:\/\/doi.org\/10.1002\/14651858.CD010813.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"7957_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Whiteman MK, Marchbanks PA, James AH, Curtis KM (2016) Progestin-only contraception and thromboembolism: a systematic review. Contraception 94(6):678\u2013700. https:\/\/doi.org\/10.1016\/j.contraception.2016.04.014","journal-title":"Contraception"},{"issue":"5","key":"7957_CR15","doi-asserted-by":"publisher","first-page":"Cd001019","DOI":"10.1002\/14651858.CD001019.pub3","volume":"5","author":"J Brown","year":"2018","unstructured":"Brown J, Crawford TJ, Datta S, Prentice A (2018) Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 5(5):Cd001019. https:\/\/doi.org\/10.1002\/14651858.CD001019.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"7957_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/beog.1999.0019","volume":"13","author":"RA Nowak","year":"1999","unstructured":"Nowak RA (1999) Fibroids: pathophysiology and current medical treatment. Best Pract Res Clin Obstet Gynaecol 13(2):223\u2013238","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"7957_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/endrev\/bnab039","volume":"43","author":"Q Yang","year":"2021","unstructured":"Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG et al (2021) Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev 43(4):678\u2013719. https:\/\/doi.org\/10.1210\/endrev\/bnab039","journal-title":"Endocr Rev"},{"key":"7957_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6874-12-6","volume":"12","author":"A Zimmermann","year":"2012","unstructured":"Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K (2012) Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health 12:1\u201311","journal-title":"BMC Womens Health"},{"issue":"2","key":"7957_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00003081-200106000-00022","volume":"44","author":"DW Stovall","year":"2001","unstructured":"Stovall DW (2001) Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol 44(2):364\u2013371. https:\/\/doi.org\/10.1097\/00003081-200106000-00022","journal-title":"Clin Obstet Gynecol"},{"issue":"10","key":"7957_CR20","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","volume":"124","author":"EA Stewart","year":"2017","unstructured":"Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R (2017) Epidemiology of uterine fibroids: a systematic review. BJOG: Int J Obstet Gynaecol 124(10):1501\u201312. https:\/\/doi.org\/10.1111\/1471-0528.14640","journal-title":"BJOG: Int J Obstet Gynaecol"},{"key":"7957_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","volume":"34","author":"FM Reis","year":"2016","unstructured":"Reis FM, Bloise E, Ortiga-Carvalho TM (2016) Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 34:13\u201324. https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.11.015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"7957_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/jc.2007-2507","volume":"93","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Fenkci V, Marsh EE, Yin P, Chen D, Cheng YH et al (2008) CCAAT\/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. J Clin Endocrinol Metab 93(3):981\u2013991. https:\/\/doi.org\/10.1210\/jc.2007-2507","journal-title":"J Clin Endocrinol Metab"},{"issue":"9619","key":"7957_CR23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","volume":"371","author":"KA Yonkers","year":"2008","unstructured":"Yonkers KA, O\u2019Brien PMS, Eriksson E (2008) Premenstrual syndrome. Lancet 371(9619):1200\u20131210. https:\/\/doi.org\/10.1016\/S0140-6736(08)60527-9","journal-title":"Lancet"},{"key":"7957_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0306-4530(03)00097-0","volume":"28","author":"U Halbreich","year":"2003","unstructured":"Halbreich U (2003) The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28:55\u201399. https:\/\/doi.org\/10.1016\/S0306-4530(03)00097-0","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"7957_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1258\/mi.2012.012014","volume":"18","author":"AJ Rapkin","year":"2012","unstructured":"Rapkin AJ, Akopians AL (2012) Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause Int 18(2):52\u201359","journal-title":"Menopause Int"},{"key":"7957_CR26","doi-asserted-by":"publisher","first-page":"Cd003415","DOI":"10.1002\/14651858.CD003415.pub4","volume":"3","author":"O Ford","year":"2012","unstructured":"Ford O, Lethaby A, Roberts H, Mol BW (2012) Progesterone for premenstrual syndrome. Cochrane Database Syst Rev 3:Cd003415. https:\/\/doi.org\/10.1002\/14651858.CD003415.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"7957_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/13625187.2018.1550576","volume":"24","author":"G Grandi","year":"2019","unstructured":"Grandi G, Barra F, Ferrero S, Sileo FG, Bertucci E, Napolitano A et al (2019) Hormonal contraception in women with endometriosis: a systematic review. Eur J Contracept Reprod Health Care 24(1):61\u201370. https:\/\/doi.org\/10.1080\/13625187.2018.1550576","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"7957_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12905-022-02122-0","volume":"22","author":"J-B Mitchell","year":"2022","unstructured":"Mitchell J-B, Chetty S, Kathrada F (2022) Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC Womens Health 22(1):526. https:\/\/doi.org\/10.1186\/s12905-022-02122-0","journal-title":"BMC Womens Health"},{"key":"7957_CR29","first-page":"372","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA et al (2020) statement: an updated guideline for reporting systematic reviews. BMJ 2021:372","journal-title":"BMJ"},{"key":"7957_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"2","key":"7957_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.fertnstert.2010.08.042","volume":"95","author":"Y Bayoglu Tekin","year":"2011","unstructured":"Bayoglu Tekin Y, Dilbaz B, Altinbas SK, Dilbaz S (2011) Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril 95(2):492\u2013496. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.08.042","journal-title":"Fertil Steril"},{"issue":"11","key":"7957_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/1933719114549848","volume":"21","author":"B Carr","year":"2014","unstructured":"Carr B, Dmowski WP, O\u2019Brien C, Jiang P, Burke J, Jimenez R et al (2014) Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reprod Sci 21(11):1341\u20131351. https:\/\/doi.org\/10.1177\/1933719114549848","journal-title":"Reprod Sci"},{"issue":"1","key":"7957_CR33","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12905-022-01737-7","volume":"22","author":"S Caruso","year":"2022","unstructured":"Caruso S, Cianci A, Iraci Sareri M, Panella M, Caruso G, Cianci S (2022) Randomized study on the effectiveness of nomegestrol acetate plus 17\u03b2-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis-associated chronic pelvic pain. BMC Womens Health 22(1):146. https:\/\/doi.org\/10.1186\/s12905-022-01737-7","journal-title":"BMC Womens Health"},{"issue":"6","key":"7957_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.fertnstert.2018.07.003","volume":"110","author":"N Carvalho","year":"2018","unstructured":"Carvalho N, Margatho D, Cursino K, Benetti-Pinto CL, Bahamondes L (2018) Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial. Fertil Steril 110(6):1129\u20131136. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.07.003","journal-title":"Fertil Steril"},{"issue":"10","key":"7957_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/09513590.2021.1929151","volume":"37","author":"M Ceccaroni","year":"2021","unstructured":"Ceccaroni M, Clarizia R, Liverani S, Donati A, Ceccarello M, Manzone M et al (2021) Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial. Gynecol Endocrinol 37(10):930\u2013933. https:\/\/doi.org\/10.1080\/09513590.2021.1929151","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"7957_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000337713","volume":"74","author":"S Cheewadhanaraks","year":"2012","unstructured":"Cheewadhanaraks S, Choksuchat C, Dhanaworavibul K, Liabsuetrakul T (2012) Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial. Gynecol Obstet Invest 74(2):151\u2013156. https:\/\/doi.org\/10.1159\/000337713","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"7957_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/humrep\/dei290","volume":"21","author":"PG Crosignani","year":"2006","unstructured":"Crosignani PG, Luciano A, Ray A, Bergqvist A (2006) Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 21(1):248\u2013256. https:\/\/doi.org\/10.1093\/humrep\/dei290","journal-title":"Hum Reprod"},{"key":"7957_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejogrb.2021.10.029","volume":"267","author":"L El Taha","year":"2021","unstructured":"El Taha L, Abu Musa A, Khalifeh D, Khalil A, Abbasi S, Nassif J (2021) Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 267:205\u2013212. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.10.029","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"7957_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.contraception.2009.08.003","volume":"81","author":"RA Ferreira","year":"2010","unstructured":"Ferreira RA, Vieira CS, Rosa-E-Silva JC, Rosa-e-Silva AC, Nogueira AA, Ferriani RA (2010) Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception 81(2):117\u2013122. https:\/\/doi.org\/10.1016\/j.contraception.2009.08.003","journal-title":"Contraception"},{"issue":"3","key":"7957_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","volume":"91","author":"T Harada","year":"2009","unstructured":"Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H et al (2009) Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2013a randomized, double-blind, multicenter, controlled trial. Fertil Steril 91(3):675\u2013681. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.12.080","journal-title":"Fertil Steril"},{"issue":"2","key":"7957_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/jwh.2017.6399","volume":"27","author":"J Lang","year":"2018","unstructured":"Lang J, Yu Q, Zhang S, Li H, Gude K, von Ludwig C et al (2018) Dienogest for treatment of endometriosis in chinese women: a placebo-controlled, randomized, double-blind phase 3 study. J Womens Health (Larchmt) 27(2):148\u2013155. https:\/\/doi.org\/10.1089\/jwh.2017.6399","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"7957_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/13625187.2020.1725461","volume":"25","author":"D Margatho","year":"2020","unstructured":"Margatho D, Carvalho NM, Bahamondes L (2020) Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months. Eur J Contracept Reprod Health Care 25(2):133\u2013140. https:\/\/doi.org\/10.1080\/13625187.2020.1725461","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"7957_CR43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejogrb.2006.08.002","volume":"135","author":"S Razzi","year":"2007","unstructured":"Razzi S, Luisi S, Ferretti C, Calonaci F, Gabbanini M, Mazzini M et al (2007) Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol 135(2):188\u2013190. https:\/\/doi.org\/10.1016\/j.ejogrb.2006.08.002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"7957_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/gye.15.3.202.209","volume":"15","author":"PA Regidor","year":"2001","unstructured":"Regidor PA, Regidor M, Schmidt M, Ruwe B, L\u00fcbben G, F\u00f6rtig P et al (2001) Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol 15(3):202\u2013209","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"7957_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","volume":"85","author":"WD Schlaff","year":"2006","unstructured":"Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A (2006) Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril 85(2):314\u2013325. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.07.1315","journal-title":"Fertil Steril"},{"issue":"2","key":"7957_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejogrb.2010.04.002","volume":"151","author":"T Strowitzki","year":"2010","unstructured":"Strowitzki T, Faustmann T, Gerlinger C, Seitz C (2010) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151(2):193\u2013198. https:\/\/doi.org\/10.1016\/j.ejogrb.2010.04.002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"7957_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/AOG.0b013e31824264c3","volume":"119","author":"P Tanmahasamut","year":"2012","unstructured":"Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P (2012) Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol 119(3):519\u2013526. https:\/\/doi.org\/10.1097\/AOG.0b013e31824264c3","journal-title":"Obstet Gynecol"},{"issue":"7","key":"7957_CR48","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/09513590.2017.1296124","volume":"33","author":"P Tanmahasamut","year":"2017","unstructured":"Tanmahasamut P, Saejong R, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Sanga-Areekul N (2017) Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial. Gynecol Endocrinol 33(7):534\u2013539. https:\/\/doi.org\/10.1080\/09513590.2017.1296124","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"7957_CR49","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.fertnstert.2005.03.083","volume":"84","author":"P Vercellini","year":"2005","unstructured":"Vercellini P, Pietropaolo G, De Giorgi O, Pasin R, Chiodini A, Crosignani PG (2005) Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 84(5):1375\u20131387. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.03.083","journal-title":"Fertil Steril"},{"issue":"1","key":"7957_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0301-2115(99)00168-2","volume":"89","author":"E Verspyck","year":"2000","unstructured":"Verspyck E, Marpeau L, Lucas C (2000) Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial. Eur J Obstet Gynecol Reprod Biol 89(1):7\u201313. https:\/\/doi.org\/10.1016\/s0301-2115(99)00168-2","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7957_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101995","author":"LHR Whitaker","year":"2023","unstructured":"Whitaker LHR, Middleton LJ, Daniels JP, Williams ARW, Priest L, Odedra S et al (2023) Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101995","journal-title":"EClinicalMedicine"},{"key":"7957_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002122.pub2","author":"J Brown","year":"2012","unstructured":"Brown J, Kives S, Akhtar M (2012) Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD002122.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"7957_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008994.pub3","author":"US Sangkomkamhang","year":"2020","unstructured":"Sangkomkamhang US, Lumbiganon P, Pattanittum P (2020) Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008994.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"7957_CR54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","volume":"73","author":"KM Curtis","year":"2006","unstructured":"Curtis KM, Martins SL (2006) Progestogen-only contraception and bone mineral density: a systematic review. Contraception 73(5):470\u2013487. https:\/\/doi.org\/10.1016\/j.contraception.2005.12.010","journal-title":"Contraception"},{"issue":"6","key":"7957_CR55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1517\/14656566.2014.888414","volume":"15","author":"C-J Jeng","year":"2014","unstructured":"Jeng C-J, Chuang L, Shen J (2014) A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review. Expert Opin Pharmacother 15(6):767\u2013773. https:\/\/doi.org\/10.1517\/14656566.2014.888414","journal-title":"Expert Opin Pharmacother"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-07957-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-07957-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-07957-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:45:27Z","timestamp":1746510327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-07957-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["7957"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-07957-0","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Saikat Banerjee is an assistant editor for Archives of Gynecology and Obstetrics. The remaining authors declare they have no competing interests that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a systematic review; therefore ethics approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}